To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.

Summary

This bill expands the tax credit for increasing research activities to add a new credit amount equal to 14% of specified medical research expenditures. The bill defines specified medical research expenditures as amounts paid or incurred for research with respect to any qualified countermeasure (i.e., a drug, biological product, or device determined to be a priority in protecting against harm from a biological agent or adverse health condition).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 14 April 2022

   Introduced

   Referred to the House Committee on Ways and Means.

   Source: IntroReferral

2. 14 April 2022

   Introduced

   Introduced in House

   Source: IntroReferral

3. 14 April 2022

   Introduced

   Introduced in House

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in House · 14 April 2022 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 14 April 2022

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 14 April 2022

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 14 April 2022

  Open at official source

Sponsors

• Vern Buchanan · R · Sponsor
• Rep. Kelly, Mike [R-PA-16] · R · Sponsor
• · hswm00 · Standing

Related records

• related to → To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.